Christine L. Hann, MD, PhD
Associate Professor of Oncology
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Christine L. Hann, MD, PhD, has disclosed that she has received consultant/advisor/speaker fees from Amgen, AstraZeneca, and Janssen and funds for research support from AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, and Genentech.
Mark A. Socinski, MD
Director, Lung Cancer Section of the Division of Hematology/Oncology
Co-Director, UPMC Center for Excellence in Lung Cancer
Co-Director, Lung and Thoracic Malignancies Program
University of Pittsburgh Cancer Institute
University of Pittsburgh
Mark A. Socinski, MD, has disclosed that he has received consultant/advisor/speaker fees from AstraZeneca, BeiGene, G1 Therapeutics, Genentech, Guardant, Janssen, Jazz, Lilly, Regeneron, Takeda, and Sanofi and funds for research support from AstraZeneca, BeiGene, Cullinan, Daiichi-Sankyo, Genentech, Novartis, Spectrum, and Takeda.